{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:13:27Z","timestamp":1790507607105,"version":"4.1.0"},"reference-count":87,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-13-1194","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T22:54:09Z","timestamp":1386802449000},"page":"42-50","source":"Crossref","is-referenced-by-count":31,"title":["Role of DNA Damage in Cardiovascular Disease"],"prefix":"10.1253","volume":"78","author":[{"given":"Takafumi","family":"Ishida","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Cellular Biology, Research Institute of Radiation Biology and Medicine, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Yoshizumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":" 1. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749–1753.","DOI":"10.1126\/science.7792600"},{"key":"2","doi-asserted-by":"crossref","unstructured":" 2. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner’s syndrome gene. Science 1996; 272: 258–262.","DOI":"10.1126\/science.272.5259.258"},{"key":"3","doi-asserted-by":"crossref","unstructured":" 3. Minamino T, Yoshida T, Tateno K, Miyauchi H, Zou Y, Toko H, et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 2003; 108: 2264–2269.","DOI":"10.1161\/01.CIR.0000093274.82929.22"},{"key":"4","doi-asserted-by":"crossref","unstructured":" 4. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006; 4: 377–389.","DOI":"10.1016\/j.cmet.2006.10.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":" 5. Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, et al. Cardiovascular pathology in Hutchinson-Gilford progeria: Correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol 2010; 30: 2301–2309.","DOI":"10.1161\/ATVBAHA.110.209460"},{"key":"6","doi-asserted-by":"crossref","unstructured":" 6. Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, et al. BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2011; 2: 593.","DOI":"10.1038\/ncomms1601"},{"key":"7","doi-asserted-by":"crossref","unstructured":" 7. Gray K, Bennett M. Role of DNA damage in atherosclerosis: Bystander or participant? Biochem Pharmacol 2011; 82: 693–700.","DOI":"10.1016\/j.bcp.2011.06.025"},{"key":"8","doi-asserted-by":"crossref","unstructured":" 8. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med 2009; 361: 1475–1485.","DOI":"10.1056\/NEJMra0804615"},{"key":"9","doi-asserted-by":"crossref","unstructured":" 9. Waris G, Ahsan H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.","DOI":"10.1186\/1477-3163-5-14"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Larrea AA, Lujan SA, Kunkel TA. SnapShot: DNA mismatch repair. Cell 2010; 141: 730, e731.","DOI":"10.1016\/j.cell.2010.05.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sulli G, Di Micco R, d’Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer 2012; 12: 709–720.","DOI":"10.1038\/nrc3344"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim YJ, Wilson DM 3rd. Overview of base excision repair biochemistry. Curr Mol Pharmacol 2012; 5: 3–13.","DOI":"10.2174\/1874-470211205010003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Houtgraaf JH, Versmissen J, van der Giessen WJ. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 2006; 7: 165–172.","DOI":"10.1016\/j.carrev.2006.02.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Li J, Bhat A, Xiao W. Regulation of nucleotide excision repair through ubiquitination. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 919–929.","DOI":"10.1093\/abbs\/gmr088"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ciccia A, Elledge SJ. The DNA damage response: Making it safe to play with knives. Mol Cell 2010; 40: 179–204.","DOI":"10.1016\/j.molcel.2010.09.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kasparek TR, Humphrey TC. DNA double-strand break repair pathways, chromosomal rearrangements and cancer. Semin Cell Dev Biol 2011; 22: 886–897.","DOI":"10.1016\/j.semcdb.2011.10.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic Acids Res 2012; 40: 5795–5818.","DOI":"10.1093\/nar\/gks270"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Goto M. Hierarchical deterioration of body systems in Werner’s syndrome: Implications for normal ageing. Mech Ageing Dev 1997; 98: 239–254.","DOI":"10.1016\/S0047-6374(97)00111-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Huang S, Lee L, Hanson NB, Lenaerts C, Hoehn H, Poot M, et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 2006; 27: 558–567.","DOI":"10.1002\/humu.20337"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966; 45: 177–221.","DOI":"10.1097\/00005792-196605000-00001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kudlow BA, Kennedy BK, Monnat RJ Jr. Werner and Hutchinson-Gilford progeria syndromes: Mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 2007; 8: 394–404.","DOI":"10.1038\/nrm2161"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rossi ML, Ghosh AK, Bohr VA. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair (Amst) 2010; 9: 331–344.","DOI":"10.1016\/j.dnarep.2009.12.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Moser MJ, Oshima J, Monnat RJ Jr. WRN mutations in Werner syndrome. Hum Mutat 1999; 13: 271–279.","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.0.CO;2-Q"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Singh DK, Ahn B, Bohr VA. Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging. Biogerontology 2009; 10: 235–252.","DOI":"10.1007\/s10522-008-9205-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Galvan N, Lim S, Zmugg S, Smith MT, Zhang L. Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone. Mutat Res 2008; 649: 54–61.","DOI":"10.1016\/j.mrgentox.2007.07.011"},{"key":"26","unstructured":"26. Oshima J, Huang S, Pae C, Campisi J, Schiestl RH. Lack of WRN results in extensive deletion at nonhomologous joining ends. Cancer Res 2002; 62: 547–551."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Von Kobbe C, May A, Grandori C, Bohr VA. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J 2004; 18: 1970–1972.","DOI":"10.1096\/fj.04-1895fje"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Harrigan JA, Wilson DM 3rd, Prasad R, Opresko PL, Beck G, May A, et al. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase beta. Nucleic Acids Res 2006; 34: 745–754.","DOI":"10.1093\/nar\/gkj475"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: Relation to aging. Proc Natl Acad Sci USA 1995; 92: 258–262.","DOI":"10.1073\/pnas.92.1.258"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wyllie FS, Jones CJ, Skinner JW, Haughton MF, Wallis C, Wynford-Thomas D, et al. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet 2000; 24: 16–17.","DOI":"10.1038\/71630"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Crabbe L, Jauch A, Naeger CM, Holtgreve-Grez H, Karlseder J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci USA 2007; 104: 2205–2210.","DOI":"10.1073\/pnas.0609410104"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004; 36: 877–882.","DOI":"10.1038\/ng1389"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Du X, Shen J, Kugan N, Furth EE, Lombard DB, Cheung C, et al. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 2004; 24: 8437–8446.","DOI":"10.1128\/MCB.24.19.8437-8446.2004"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 2000; 20: 3286–3291.","DOI":"10.1128\/MCB.20.9.3286-3291.2000"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Su Y, Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 2000; 133: 770–778.","DOI":"10.7326\/0003-4819-133-10-200011210-00009"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P. ATM and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 1997; 16: 397–401.","DOI":"10.1038\/ng0897-397"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm–\/–<\/sup> mice. Mol Cell Biol 1998; 18: 4385–4390.","DOI":"10.1128\/MCB.18.7.4385"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hennekam RC. Hutchinson-Gilford progeria syndrome: Review of the phenotype. Am J Med Genet A 2006; 140: 2603–2624.","DOI":"10.1002\/ajmg.a.31346"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 2008; 358: 592–604.","DOI":"10.1056\/NEJMoa0706898"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003; 423: 293–298.","DOI":"10.1038\/nature01629"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003; 300: 2055.","DOI":"10.1126\/science.1084125"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2004; 101: 8963–8968.","DOI":"10.1073\/pnas.0402943101"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 2002; 31: 94–99.","DOI":"10.1038\/ng871"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Davies BS, Barnes RH 2nd, Tu Y, Ren S, Andres DA, Spielmann HP, et al. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. Hum Mol Genet 2010; 19: 2682–2694.","DOI":"10.1093\/hmg\/ddq158"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005; 437: 564–568.","DOI":"10.1038\/nature04019"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Schreiber KH, Kennedy BK. When lamins go bad: Nuclear structure and disease. Cell 2013; 152: 1365–1375.","DOI":"10.1016\/j.cell.2013.02.015"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, et al. Genomic instability in laminopathy-based premature aging. Nat Med 2005; 11: 780–785.","DOI":"10.1038\/nm1266"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Liu Y, Rusinol A, Sinensky M, Wang Y, Zou Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci 2006; 119: 4644–4649.","DOI":"10.1242\/jcs.03263"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Liu Y, Wang Y, Rusinol AE, Sinensky MS, Liu J, Shell SM, et al. Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A. FASEB J 2008; 22: 603–611.","DOI":"10.1096\/fj.07-8598com"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011; 472: 221–225.","DOI":"10.1038\/nature09879"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006; 312: 1059–1063.","DOI":"10.1126\/science.1127168"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Mahmoudi M, Gorenne I, Mercer J, Figg N, Littlewood T, Bennett M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res 2008; 103: 717–725.","DOI":"10.1161\/CIRCRESAHA.108.182899"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106: 927–932.","DOI":"10.1161\/01.CIR.0000026393.47805.21"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266–2274.","DOI":"10.1172\/JCI117917"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 2002; 105: 1541–1544.","DOI":"10.1161\/01.CIR.0000013836.85741.17"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Cohen JI, Arnett EN, Kolodny AL, Roberts WC. Cardiovascular features of the Werner syndrome. Am J Cardiol 1987; 59: 493–495.","DOI":"10.1016\/0002-9149(87)90970-2"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Minamino T, Komuro I. Vascular aging: Insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med 2008; 5: 637–648.","DOI":"10.1038\/ncpcardio1324"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Okabe E, Takemoto M, Onishi S, Ishikawa T, Ishibashi R, He P, et al. Incidence and characteristics of metabolic disorders and vascular complications in individuals with Werner syndrome in Japan. J Am Geriatr Soc 2012; 60: 997–998.","DOI":"10.1111\/j.1532-5415.2012.03944.x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Massip L, Garand C, Turaga RV, Deschenes F, Thorin E, Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. Exp Gerontol 2006; 41: 157–168.","DOI":"10.1016\/j.exger.2005.10.011"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Capell BC, Collins FS, Nabel EG. Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res 2007; 101: 13–26.","DOI":"10.1161\/CIRCRESAHA.107.153692"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Mercer JR, Cheng KK, Figg N, Gorenne I, Mahmoudi M, Griffin J, et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 2010; 107: 1021–1031.","DOI":"10.1161\/CIRCRESAHA.110.218966"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Zhan H, Suzuki T, Aizawa K, Miyagawa K, Nagai R. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J Biol Chem 2010; 285: 29662–29670.","DOI":"10.1074\/jbc.M110.125138"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004; 431: 997–1002.","DOI":"10.1038\/nature02989"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Gabr M, Hashem N, Hashem M, Fahmi A, Safouh M. Progeria, a pathologic study. J Pediatr 1960; 57: 70–77.","DOI":"10.1016\/S0022-3476(60)80213-2"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Stehbens WE, Wakefield SJ, Gilbert-Barness E, Olson RE, Ackerman J. Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol 1999; 8: 29–39.","DOI":"10.1016\/S1054-8807(98)00023-4"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Stehbens WE, Delahunt B, Shozawa T, Gilbert-Barness E. Smooth muscle cell depletion and collagen types in progeric arteries. Cardiovasc Pathol 2001; 10: 133–136.","DOI":"10.1016\/S1054-8807(01)00069-2"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Varga R, Eriksson M, Erdos MR, Olive M, Harten I, Kolodgie F, et al. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2006; 103: 3250–3255.","DOI":"10.1073\/pnas.0600012103"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Makous N, Friedman S, Yakovac W, Maris EP. Cardiovascular manifestations in progeria: Report of clinical and pathologic findings in a patient with severe arteriosclerotic heart disease and aortic stenosis. Am Heart J 1962; 64: 334–346.","DOI":"10.1016\/0002-8703(62)90148-5"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, et al. A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011; 8: 31–45.","DOI":"10.1016\/j.stem.2010.12.002"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, et al. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010; 76: 656–665.","DOI":"10.1016\/j.ijrobp.2009.09.064"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987–998.","DOI":"10.1056\/NEJMoa1209825"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Plummer C, Henderson RD, O’Sullivan JD, Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: A review. Stroke 2011; 42: 2410–2418.","DOI":"10.1161\/STROKEAHA.111.615203"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ 2010; 340: b5349.","DOI":"10.1136\/bmj.b5349"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958–1998. Radiat Res 2004; 161: 622–632.","DOI":"10.1667\/RR3183"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res 1999; 151: 736–746.","DOI":"10.2307\/3580213"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Yamada M, Naito K, Kasagi F, Masunari N, Suzuki G. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: An RERF Adult Health Study. Int J Radiat Biol 2005; 81: 821–826.","DOI":"10.1080\/09553000600555504"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol 2003; 79: 129–136.","DOI":"10.1080\/713865035"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Kusunoki Y, Kyoizumi S, Hirai Y, Suzuki T, Nakashima E, Kodama K, et al. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiat Res 1998; 150: 227–236.","DOI":"10.2307\/3579858"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Stewart FA, Heeneman S, Te Poele J, Kruse J, Russell NS, Gijbels M, et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE–\/–<\/sup> mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 2006; 168: 649–658.","DOI":"10.2353\/ajpath.2006.050409"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Hoving S, Heeneman S, Gijbels MJ, te Poele JA, Russell NS, Daemen MJ, et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(–\/–) mice. Int J Radiat Oncol Biol Phys 2008; 71: 848–857.","DOI":"10.1016\/j.ijrobp.2008.02.031"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003; 42: 743–749.","DOI":"10.1016\/S0735-1097(03)00759-9"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Wethal T, Lund MB, Edvardsen T, Fossa SD, Pripp AH, Holte H, et al. Valvular dysfunction and left ventricular changes in Hodgkin’s lymphoma survivors: A longitudinal study. Br J Cancer 2009; 101: 575–581.","DOI":"10.1038\/sj.bjc.6605191"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685–705.","DOI":"10.1146\/annurev-physiol-030212-183653"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75: 2739–2748.","DOI":"10.1253\/circj.CJ-11-1184"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Simon DI. Inflammation and vascular injury: Basic discovery to drug development. Circ J 2012; 76: 1811–1818.","DOI":"10.1253\/circj.CJ-12-0801"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009; 15: 1082–1087.","DOI":"10.1038\/nm.2014"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Minamino T. Role of cellular senescence in lifestyle-related disease. Circ J 2010; 74: 2527–2533.","DOI":"10.1253\/circj.CJ-10-0916"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-1194\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T04:12:01Z","timestamp":1616645521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-1194\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-13-1194","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}